Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial officer, will present a company overview at the Piper Sandler 37^th Annual Healthcare Conference on Wednesday, December 3, 2025, at 8:30 am ET.

Read more at prnewswire.com